Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature

Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature

Abstract Background Primary central nervous system lymphoma(PCNSL) is a rare kind of non-Hodgkin lymphoma. Rituximab combined with high-dose methotrexate, cytarabine and dexamethasone (R-MAD regimen) were reported effective for PCNSL patients. Rituximab can cause several side effects, including feve...

Full description

Bibliographic Details
Main Authors: Yuchen Wu, Xuefei Sun, Jing Liu, Jun Qian, Xueyan Bai, Yuedan Chen, Yuanbo Liu
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Chinese Neurosurgical Journal
Subjects:
Central nervous system neoplasm
Lymphoma
Interstitial pneumonitis
Rituximab
R-MAD regimen
Rituximab induced lung disease
Online Access:http://link.springer.com/article/10.1186/s41016-017-0106-3

Internet

http://link.springer.com/article/10.1186/s41016-017-0106-3

Similar Items